Ticker Details
Tandem Diabetes Care, Inc. Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.
IPO Date:	December 1, 2013
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$1.35B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.94 | 2.78%
Avg Daily Range (30 D):	$0.56 | 2.56%
Avg Daily Range (90 D):	$0.56 | 2.57%

Institutional Daily Volume
Avg Daily Volume:	.96M
Avg Daily Volume (30 D):	1.57M
Avg Daily Volume (90 D):	1.54M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	7,125
Avg Institutional Trade:	$2.75M
Avg Institutional Trade (30 D):	$2.26M
Avg Institutional Trade (90 D):	$2.43M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$4.87M
Avg Closing Trade (30 D):	$5.13M
Avg Closing Trade (90 D):	$4.64M
Avg Closing Volume:	111.58K

News

Mar 27, 2026 @ 1:00 PM Tandem Diabetes Care, Inc. Investigated by the Por... Source: Portnoy Law Firm

Mar 9, 2026 @ 10:30 PM [Latest] Global Intravenous Infusion Pump Market S... Source: Custom Market Insights

Feb 20, 2026 @ 6:01 PM Tandem Diabetes Shares Rise 33% On Earnings Beat, ... Source: Vandana Singh

Feb 8, 2026 @ 5:23 PM TNDM Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm

Feb 6, 2026 @ 1:24 AM TNDM Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.04	$-.01	$-3.04
Diluted EPS	$-3.04	$-.01	$-3.04
Revenue	$1.01B	$290.38M	$1.01B
Gross Profit	$546.01M	$167.46M	$546.01M
Net Income / Loss	$-204.71M	$-.59M	$-204.71M
Operating Income / Loss	$-187.26M	$8.29M	$-187.26M
Cost of Revenue	$468.72M	$122.92M	$468.72M
Net Cash Flow	$21.4M	$-1.31M	$21.4M
PE Ratio

Splits
Oct 10, 2017	1:10